In order to detect the underlying mechanisms of the Rac1 inhibitor on chemoresistance of HCC cells to sorafenib, RNA sequencing (RNA-seq) was performed to explore mRNA profiles in different groups. This evidence concerns the gene RAC1 and hepatocellular carcinoma.